» Articles » PMID: 27478827

Subclinical Hypothyroidism in PCOS: Impact on Presentation, Insulin Resistance, and Cardiovascular Risk

Overview
Journal Biomed Res Int
Publisher Wiley
Date 2016 Aug 2
PMID 27478827
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Aim of Study. To assess status of thyroid function and thyroid disorders particularly subclinical hypothyroidism (SCH) in subjects with polycystic ovarian syndrome (PCOS) and impact of SCH on various clinical and biochemical parameters and cardiovascular risk in PCOS. Methods. Hundred females diagnosed with PCOS as per Rotterdam criteria and 100 normal controls were recruited and were subjected to elaborate anthropometric, clinical, and biochemical assessment. Results. Notable findings included significantly higher frequency of subjects with subclinical hypothyroidism (p = 0.0002), autoimmune thyroiditis (p < 0.001), and goitre (p = 0.02) in polycystic ovarian syndrome subjects compared to control subjects. Further SCH PCOS subjects were found to harbor significantly higher HOMA-IR (p < 0.05) and frequency of subjects with dyslipidemia (p < 0.05) compared to both euthyroid PCOS and euthyroid control subjects. Though frequency of subjects with cardiovascular risk factors was higher in SCH PCOS group than euthyroid PCOS group, it failed to reach statistical significance. Conclusion. We concluded that PCOS is associated with high incidence of SCH and AIT compared to normal population and SCH poses increased risk of cardiovascular disorder in PCOS.

Citing Articles

Correlation between thyroid hormone sensitivity and the risk of polycystic ovary syndrome.

Wang Q, Zhao R, Han C, Huang Z, Bi Y, Zhang X BMC Endocr Disord. 2024; 24(1):76.

PMID: 38816692 PMC: 11137887. DOI: 10.1186/s12902-024-01607-3.


Endometriosis, polycystic ovary syndrome, and the thyroid: a review.

Kirkegaard S, Torp N, Andersen S, Andersen S Endocr Connect. 2023; 13(2).

PMID: 38078917 PMC: 10831546. DOI: 10.1530/EC-23-0431.


The role of the thyroid in polycystic ovary syndrome.

Fan H, Ren Q, Sheng Z, Deng G, Li L Front Endocrinol (Lausanne). 2023; 14:1242050.

PMID: 37867519 PMC: 10585146. DOI: 10.3389/fendo.2023.1242050.


Maternal preconception thyroid autoimmunity is associated with neonatal birth weight conceived by PCOS women undergoing their first in vitro fertilization/intracytoplasmic sperm injection.

Jiang H, Chen L, Huang N, Shi H, Chi H, Yang R J Ovarian Res. 2023; 16(1):140.

PMID: 37452360 PMC: 10347740. DOI: 10.1186/s13048-023-01208-z.


A study of hormonal and anthropometric parameters in polycystic ovarian syndrome.

Kambale T, Sawaimul K, Prakash S Ann Afr Med. 2023; 22(1):112-116.

PMID: 36695232 PMC: 10064907. DOI: 10.4103/aam.aam_15_22.


References
1.
Singla R, Gupta Y, Khemani M, Aggarwal S . Thyroid disorders and polycystic ovary syndrome: An emerging relationship. Indian J Endocrinol Metab. 2015; 19(1):25-9. PMC: 4287775. DOI: 10.4103/2230-8210.146860. View

2.
Ramanand S, Ghongane B, Ramanand J, Patwardhan M, Ghanghas R, Jain S . Clinical characteristics of polycystic ovary syndrome in Indian women. Indian J Endocrinol Metab. 2013; 17(1):138-45. PMC: 3659881. DOI: 10.4103/2230-8210.107858. View

3.
Celik C, Abali R, Tasdemir N, Guzel S, Yuksel A, Aksu E . Is subclinical hypothyroidism contributing dyslipidemia and insulin resistance in women with polycystic ovary syndrome?. Gynecol Endocrinol. 2012; 28(8):615-8. DOI: 10.3109/09513590.2011.650765. View

4.
Sinha U, Sinharay K, Saha S, Longkumer T, Baul S, Pal S . Thyroid disorders in polycystic ovarian syndrome subjects: A tertiary hospital based cross-sectional study from Eastern India. Indian J Endocrinol Metab. 2013; 17(2):304-9. PMC: 3683210. DOI: 10.4103/2230-8210.109714. View

5.
Essah P, Nestler J, Carmina E . Differences in dyslipidemia between American and Italian women with polycystic ovary syndrome. J Endocrinol Invest. 2008; 31(1):35-41. DOI: 10.1007/BF03345564. View